atogepant
atogepant is listed in the FDA National Drug Code directory with 3 NDC codes. Available dosage form: tablet.
Drug details
- Generic Name
- atogepant
- Sponsor
- AbbVie Inc.
- NDC Codes
- 3
- Dosage Forms
- TABLET
- Active Ingredients
- ATOGEPANT
Indications and Usage
1 INDICATIONS AND USAGE QULIPTA is indicated for the preventive treatment of migraine in adults. QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 )